Heart Rhythm
Volume 6, Issue 5 , Pages 605-610, May 2009

Increasing hazard of Sprint Fidelis implantable cardioverter-defibrillator lead failure

  • Robert G. Hauser, MD, FHRS

      Affiliations

    • Corresponding Author InformationAddress reprint requests and correspondence: Dr. Robert G. Hauser, Minneapolis Heart Institute, 920 East 28th Street, Suite 300, Minneapolis, Minnesota 55407
    • ,
  • David L. Hayes, MD, FHRS

Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, and Mayo Clinic, Rochester, Minnesota

Received 23 January 2009; accepted 11 February 2009. published online 23 February 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Dr. Hayes has received honoraria from Medtronic, Boston Scientific [Guidant], St. Jude Medical, Sorin/ELA, and Blackwell/Wiley; has served and/or is serving on an Advisory Board of Boston Scientific (Guidant), St. Jude Medical, Sorin/ELA, and AI-Semi; serves on a Steering Committee of St. Jude (DSMB); and has received royalties from Blackwell/Futura.

PII: S1547-5271(09)00175-1

doi:10.1016/j.hrthm.2009.02.024

Heart Rhythm
Volume 6, Issue 5 , Pages 605-610, May 2009

Article Tools

* Image Usage & Resolution